FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082507969> ?p ?o ?g. }

• W2082507969 endingPage "283" @default.
• W2082507969 startingPage "277" @default.
• W2082507969 abstract "There is no reliable way to identify the high-risk patients with intermediate coronary artery lesions (diameter stenosis 20%-70%) in early stage. Soluble CXC chemokine ligand 16 (CXCL16) is a newly discovered chemokine that can mediate inflammatory responses. It is released by proteolytic cleavage of its membrane-bound form, named scavenger receptor for phosphatidylserine and oxidized lipoprotein (SR-PSOX) that can promote the uptake of oxidized low-density lipoprotein cholesterol by macrophages. We have hypothesized that CXCL16 is an indicator of the prognosis of intermediate coronary artery lesions, and thus assessed the association between plasma CXCL16 concentrations and the 2-year prognosis in 616 patients with intermediate coronary artery lesions. The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, revascularization and angina pectoris requiring re-hospitalization. During the median follow-up time of 24 months, 69 events occurred. The plasma concentrations of CXCL16 (median 7712.88 pg/ml vs. 6792.43 pg/ml, P = 0.014) and high-sensitivity C-reactive protein (hs-CRP) (median 2.82 mg/L vs. 1.68 mg/L, P < 0.001) were higher in patients with events than patients without events. Cox hazard proportion analysis showed patients in upper CXCL16 quartile were more likely to suffer from adverse outcome than patients in lower quartile (RR = 1.271, P = 0.029, 95% CI: 1.025-1.577) after adjusting for sex, age, smoking, hypertension, diabetes, fat, dyslipidemia, hs-CRP, and medication use. In conclusion, plasma level of CXCL16 is an independent predictor of the prognosis of the patients with intermediate coronary lesions. Elevated plasma CXCL16 is associated with higher risk for these patients." @default.
• W2082507969 created "2016-06-24" @default.
• W2082507969 creator A5002977329 @default.
• W2082507969 creator A5003260607 @default.
• W2082507969 creator A5004095831 @default.
• W2082507969 creator A5004716871 @default.
• W2082507969 creator A5004959591 @default.
• W2082507969 creator A5009953160 @default.
• W2082507969 creator A5017068617 @default.
• W2082507969 creator A5019130175 @default.
• W2082507969 creator A5028471707 @default.
• W2082507969 creator A5034412733 @default.
• W2082507969 creator A5040246834 @default.
• W2082507969 creator A5044316603 @default.
• W2082507969 creator A5046866473 @default.
• W2082507969 creator A5048047268 @default.
• W2082507969 creator A5049870637 @default.
• W2082507969 creator A5055481715 @default.
• W2082507969 creator A5065077694 @default.
• W2082507969 creator A5070011429 @default.
• W2082507969 creator A5073931873 @default.
• W2082507969 creator A5075392948 @default.
• W2082507969 creator A5075647045 @default.
• W2082507969 creator A5079908947 @default.
• W2082507969 creator A5080427269 @default.
• W2082507969 creator A5083506671 @default.
• W2082507969 creator A5084136821 @default.
• W2082507969 creator A5091158151 @default.
• W2082507969 date "2011-01-01" @default.
• W2082507969 modified "2023-09-27" @default.
• W2082507969 title "CXC Chemokine Ligand 16 as a Prognostic Marker in Patients with Intermediate Coronary Artery Lesions: A 2-Year Follow-Up Study" @default.
• W2082507969 cites W1820208960 @default.
• W2082507969 cites W1969709181 @default.
• W2082507969 cites W2006860639 @default.
• W2082507969 cites W2011009843 @default.
• W2082507969 cites W2011748629 @default.
• W2082507969 cites W2031397753 @default.
• W2082507969 cites W2032974245 @default.
• W2082507969 cites W2034301871 @default.
• W2082507969 cites W2042400962 @default.
• W2082507969 cites W2052671730 @default.
• W2082507969 cites W2054544120 @default.
• W2082507969 cites W2055665660 @default.
• W2082507969 cites W2073751205 @default.
• W2082507969 cites W2105173724 @default.
• W2082507969 cites W2106246085 @default.
• W2082507969 cites W2109111384 @default.
• W2082507969 cites W2113903712 @default.
• W2082507969 cites W2128471953 @default.
• W2082507969 cites W2163092745 @default.
• W2082507969 cites W2166083817 @default.
• W2082507969 doi "https://doi.org/10.1620/tjem.223.277" @default.
• W2082507969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21467783" @default.
• W2082507969 hasPublicationYear "2011" @default.
• W2082507969 type Work @default.
• W2082507969 sameAs 2082507969 @default.
• W2082507969 citedByCount "10" @default.
• W2082507969 countsByYear W20825079692013 @default.
• W2082507969 countsByYear W20825079692015 @default.
• W2082507969 countsByYear W20825079692016 @default.
• W2082507969 countsByYear W20825079692019 @default.
• W2082507969 countsByYear W20825079692020 @default.
• W2082507969 countsByYear W20825079692022 @default.
• W2082507969 countsByYear W20825079692023 @default.
• W2082507969 crossrefType "journal-article" @default.
• W2082507969 hasAuthorship W2082507969A5002977329 @default.
• W2082507969 hasAuthorship W2082507969A5003260607 @default.
• W2082507969 hasAuthorship W2082507969A5004095831 @default.
• W2082507969 hasAuthorship W2082507969A5004716871 @default.
• W2082507969 hasAuthorship W2082507969A5004959591 @default.
• W2082507969 hasAuthorship W2082507969A5009953160 @default.
• W2082507969 hasAuthorship W2082507969A5017068617 @default.
• W2082507969 hasAuthorship W2082507969A5019130175 @default.
• W2082507969 hasAuthorship W2082507969A5028471707 @default.
• W2082507969 hasAuthorship W2082507969A5034412733 @default.
• W2082507969 hasAuthorship W2082507969A5040246834 @default.
• W2082507969 hasAuthorship W2082507969A5044316603 @default.
• W2082507969 hasAuthorship W2082507969A5046866473 @default.
• W2082507969 hasAuthorship W2082507969A5048047268 @default.
• W2082507969 hasAuthorship W2082507969A5049870637 @default.
• W2082507969 hasAuthorship W2082507969A5055481715 @default.
• W2082507969 hasAuthorship W2082507969A5065077694 @default.
• W2082507969 hasAuthorship W2082507969A5070011429 @default.
• W2082507969 hasAuthorship W2082507969A5073931873 @default.
• W2082507969 hasAuthorship W2082507969A5075392948 @default.
• W2082507969 hasAuthorship W2082507969A5075647045 @default.
• W2082507969 hasAuthorship W2082507969A5079908947 @default.
• W2082507969 hasAuthorship W2082507969A5080427269 @default.
• W2082507969 hasAuthorship W2082507969A5083506671 @default.
• W2082507969 hasAuthorship W2082507969A5084136821 @default.
• W2082507969 hasAuthorship W2082507969A5091158151 @default.
• W2082507969 hasBestOaLocation W20825079691 @default.
• W2082507969 hasConcept C126322002 @default.
• W2082507969 hasConcept C12823836 @default.
• W2082507969 hasConcept C13373296 @default.
• W2082507969 hasConcept C135576274 @default.
• W2082507969 hasConcept C164705383 @default.
• W2082507969 hasConcept C207103383 @default.

• next